Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $8.28M.
ENTERPRISE VALUE (EV)
$8.28M
Cocrystal Pharma, Inc.
Market Cap
$15.30M
Enterprise Value (EV)
$8.28M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | $15.30M | $8.28M |
| Jin Medical International Ltd. (ZJYL)vs › | $15.58M | $27.07M |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | $20.98M |
| BioCardia, Inc. (BCDA)vs › | $15.78M | $11.95M |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | $175.63M |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | $6.59M |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | $20.14M |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | $10.92M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | $19.61M |
Market Cap
$15.30M
Total Debt
$0.00
Cash
$7.03M
Enterprise Value
$8.28M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
